MktsMarkets

Sana Biotechnology, Inc.
NASDAQ: SANAKey statistics
SANA News
Stories mentioning SANA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 28,719 | 34,924 | 30,106 | 29,761 | 37,189 | 45,145 | 53,206 | 60,874 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 48,614 | 61,199 | 43,515 | 94,975 | 50,630 | 50,866 | 61,761 | 49,372 |
| Operating Income (Loss) | (48,614) | (61,199) | (43,515) | (94,975) | (50,630) | (50,866) | (61,761) | (49,372) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 453.00 | 1,098 | 360.00 | 598.00 | 249.00 | 141.00 | (742.00) | (4,121) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (47,210) | (58,825) | (42,152) | (93,800) | (49,389) | (49,069) | (59,924) | (50,291) |
| Earnings Per Share (Basic) | (0.17) | (0.23) | (0.16) | (0.39) | (0.21) | (0.21) | (0.25) | (0.21) |
| Earnings Per Share (Diluted) | (0.17) | (0.23) | (0.16) | (0.39) | (0.21) | (0.21) | (0.25) | (0.21) |
| Weighted Average Shares Outstanding (Basic) | 276,856 | 253,234 | 260,494 | 238,409 | 237,578 | 230,891 | 235,412 | 234,440 |
| Weighted Average Shares Outstanding (Diluted) | 276,856 | 253,234 | 260,494 | 238,409 | 237,578 | 230,891 | 235,412 | 234,440 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SANA
Sana Biotechnology, Inc. (NASDAQ: SANA) is a stock listed on the Nasdaq Stock Market under the ticker symbol SANA. It last traded at $2.02 (Nov 13, 2026, 4:00 PM ET), up 0.5% on the day. That gives Sana Biotechnology a market capitalisation of $605.3M.
Over the past 52 weeks SANA has traded between $2.00 and $5.49.
For the quarter ended Mar 31, 2026 it reported a net loss of $47.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$47.2M |
| Dec 31, 2025 | — | -$58.8M |
| Sep 30, 2025 | — | -$42.2M |
| Jun 30, 2025 | — | -$93.8M |
From Sana Biotechnology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…